Gliotoxin

Gliotoxin
Names
	IUPAC name (3R,6S,10aR)-6-Hydroxy-3-(hydroxymethyl)-2-methyl-2,3,6,10-tetrahydro-5aH-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione
Identifiers
CAS Number	67-99-2 ;
3D model (JSmol)	Interactive image ;
ChEMBL	ChEMBL331627 ; ChEMBL145588 ;
ChemSpider	5988 ;
ECHA InfoCard	100.163.992
PubChem CID	6223 ;
UNII	5L648PH06K ;
CompTox Dashboard (EPA)	DTXSID60877179 ;
	InChI InChI=1S/C13H14N2O4S2/c1-14-10(18)12-5-7-3-2-4-8(17)9(7)15(12)11(19)13(14,6-16)21-20-12/h2-4,8-9,16-17H,5-6H2,1H3/t8-,9-,12+,13+/m0/s1 Key: FIVPIPIDMRVLAY-RBJBARPLSA-N ; InChI=1S/C13H14N2O4S2/c1-14-10(18)12-5-7-3-2-4-8(17)9(7)15(12)11(19)13(14,6-16)21-20-12/h2-4,8-9,16-17H,5-6H2,1H3/t8-,9-,12+,13+/m0/s1 Key: FIVPIPIDMRVLAY-RBJBARPLBT; Key: FIVPIPIDMRVLAY-RBJBARPLSA-N;
	SMILES O=C1N([C@@]2(SS[C@@]14N(C2=O)[C@H]3C(=C\C=C/[C@@H]3O)/C4)CO)C;
Properties
Chemical formula	C13H14N2O4S2
Molar mass	326.39 g·mol−1
Appearance	White to light yellow solid
Density	1.75 g/ml
Solubility in DMSO	soluble
Hazards
Safety data sheet (SDS)	MSDS from Fermentek
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Last updated June 08, 2024

Gliotoxin is a sulfur-containing mycotoxin that belongs to a class of naturally occurring 2,5-diketopiperazines ^[1] produced by several species of fungi, especially those of marine origin. It is the most prominent member of the epipolythiopiperazines, a large class of natural products featuring a diketopiperazine with di- or polysulfide linkage. These highly bioactive compounds have been the subject of numerous studies aimed at new therapeutics.^[2] Gliotoxin was originally isolated from Gliocladium fimbriatum , and was named accordingly. It is an epipolythiodioxopiperazine metabolite that is one of the most abundantly produced metabolites in human invasive Aspergillosis (IA).^[3]

Occurrence

The compound is produced by human pathogens such as Aspergillus fumigatus ,^[4] and also by species of Trichoderma and Penicillium . Gliotoxin has also been reported from yeasts of the genus Candida ,^[5] but results from other studies have cast doubt on the production of this metabolite by Candida fungi.^[6]^[7] Gliotoxin is not produced by nonpathogenic A. fischeri although A.fischeri contains a gene cluster that is homologous to the gliotoxin gene cluster found in the pathogenic A. fumigatus.^[8] Gliotoxin contributes to the pathogenicity of opportunistic fungi by suppressing the immune system response of its host.^[9] Gliotoxin additionally possesses fungicidal and bacteriostatic properties, which indicates that it likely plays an important self defense role against bacteria and other fungi for the fungi that produce gliotoxin.^[10] Exposure of A. fumigatus to exogenous gliotoxin resulted in aberrant protein expression, especially in those strains that lacked the self-protection protein GliT.^[11] There is additional evidence for differential gliotoxin sensitivities amongst fungi including Aspergillus flavus , Fusarium graminearum , and Aspergillus oryzae .^[11]

Discovery

Gliotoxin was first described in 1936 by Weindling and Emerson as a metabolic product from the fungus Trichoderma lignorum . However, afterwards Weindling reported that the fungus had been misidentified based on the advice of C. Thom and M. Timonin, and that the compound instead was isolated from Gliocladium finbriatum.^[12] Contention remains on whether the fungus used by Weindling was G. finbriatum or a species of Trichoderma.^[12] The chemical structure of gliotoxin was resolved in 1958 by Bell et al. by treatment of gliotoxin on alkaline alumina.^[13] Bell and colleagues were able to determine through their structural analyses that the attachment of the disulfide bridge could not occur at any positions other than 3 and 11. This led to the elucidation that gliotoxin was an anhydropeptide related to the amino acids serine and phenylalanine. Additionally, they found that it was noteworthy that the α-carbon atoms of the cooperating α-thio-α-amino acids must have the same configuration.^[13]

Mechanism of action

Gliotoxin is suspected to be an important virulence factor (aka pathogenicity factor) in Aspergillus fungus. Gliotoxin possesses immunosuppressive properties that may suppress and cause apoptosis in certain cells of the immune system, including neutrophils, eosinophils, granulocytes, macrophages, and thymocytes.^[14] Specifically, neutrophils exposed to gliotoxin release less reactive oxygen species (ROS) and complete fewer phagocytic activities.^[15] Gliotoxin is also believed to interfere with T-cell activation.^[16] Additionally, gliotoxin acts as an inhibitor of farnesyl transferase. It noncompetitively inhibits the chymotrypsin-like activity of the 20S proteasome.^[14]

In vivo gliotoxin displays anti-inflammatory activity. It was investigated as an antibiotic and antifungal in the 1940s and as an antiviral agent.^[14] Gliotoxin inactivates many different enzymes, including nuclear factor-κB (NF-κB), NADPH oxidase, and glutaredoxin. The inhibition of NF-κB leads prevents cytokine release and induction of the inflammatory response.^[17]

The immunosuppressive properties of gliotoxin are due to the disulfide bridge within its structure. Interactions occur between sulfur molecules that make up the disulfide bridge and thiol groups contained in cysteine residues. Gliotoxin acts by blocking thiol residues in the cell membrane.^[14] Gliotoxin also activates a member of the Bcl-2 family called Bak in order to mediate cell apoptosis. Activated Bak then causes the release of ROS, which form pores within the mitochondrial membrane. These pores allow the release of cytochrome C and AIF, which initiate apoptosis within the cell.^[16]

Biosynthesis

In Aspergillus fumigatus , the enzymes needed for gliotoxin biosynthesis are encoded in 13 genes within the gli gene cluster. When this gene cluster is activated, these enzymes mediate the production of gliotoxin from serine and phenylalanine residues.^[17] The function of some genes contained within the gli gene cluster remain to be elucidated.^[18]

Enzymes Involved in Biosynthesis (in order of activity)^[17]^[18]

GliZ: transcription factor that regulates expression of gli gene cluster

GliP: non-ribosomal peptide synthetase that facilitates formation of cyclo-phenylalanyl-serine intermediate from serine and phenylalanine residues

GliC: cytochrome P450 monooxygenase that adds hydroxyl group to the alpha carbon of the phenylalanine residue in the cyclo-phenylalanyl-serine intermediate

GliG: glutathione S-transferase (GST) that adds two glutathione molecules forming a bis-glutathionylated intermediate

GliK: gamma-glutamyl transferase that removes gamma-glutamyl moieties from glutathione additions

GliJ: Cys-Gly carboxypeptidase that removes carboxyl moieties from glutathione additions

GliI: aminotransferase that removes amino moieties from glutathione additions

GliF: cytochrome P450 monooxygenase that adds hydroxyl group to the benzene residue and facilitates ring closure

GliN/GliM: N-methyltransferase/O-methyltransferase that adds a methyl group to nitrogen to form the dithiol gliotoxin intermediate utilizing s-adenosyl methionine (SAM) in the reaction

GliT: oxidoreductase thioredoxin that mediates closure of the disulfide-bridge

GliA: Major Facilitator Superfamily transporter that secretes gliotoxin across cell membrane

The exact roles of the enzymes GliC, GliF, GliM, and GliN and the steps in the biosynthetic pathway of these enzymes are still not completely understood in the biosynthesis of gliotoxin.^[18]

Regulation of Biosynthesis

Some gliotoxin molecules are not secreted by GliA and remain in the cell. This intracellular gliotoxin activates the transcription factor GliZ, facilitating gli gene cluster expression, and an enzyme called GtmA (S-adenosylmethionine (SAM)-dependent bis-thiomethyltransferase). GtmA acts as a negative regulator for gliotoxin biosynthesis by adding methyl groups to the two sulfur residues on the dithiol gliotoxin intermediate to form bisdethilobis(methylthio)-gliotoxin (BmGT).^[18] These additions prevent the formation of the disulfide bridge by GliT, inhibiting gliotoxin formation, while BmGT is significantly less toxic than gliotoxin.^[17]^[18]

It is thought that GliA, GtmA, and GliT provide mechanisms for self-protection against gliotoxin toxicity for the fungi that produce and excrete gliotoxin.^[18] GliA is a transporter involved in the secretion of gliotoxin, and it has been found that depletion of the GliA protein would result in cell death in A. fumigatus and significantly increase A. fumigatus sensitivity to gliotoxin.^[18] GtmA catalyzes the addition of methyl groups to the sulfur residues of dithiol gliotoxin to form nontoxic BmGT, which reduces the toxicity load on the fungi while also downregulating further expression of the gli cluster and attenuating gliotoxin biosynthesis.^[17] GliT is required for the formation of the disulfide bridge to create active gliotoxin, but it is also suggested that it plays a role in self-protection against gliotoxin toxicity. In A. fumigatus with the deletion of the GliT gene, there was found to be an accumulation of dithiol gliotoxin, which contributed to hypersensitivity to exogenous gliotoxin. These regulatory controls on the biosynthesis of gliotoxin are thought to provide mechanisms for novel strategies of gliotoxin toxicity prevention.^[18]

Chemical synthesis

The first total synthesis of gliotoxin was achieved by Fukuyama and Kishi in 1976.^[19] Gliotoxin contains a total of four asymmetric centers along with two ring systems—hydrated benzene and epidithiapiperazinedione. Fukuyama and Kishi first synthesized the thioacetal 1 from glycine sarcosine anhydride via a six-step synthesis with an overall 30% yield.^[19] A Michael reaction of 4-carbo-tert-butoxybenzene oxide 2 in excess in a solvent of dimethyl sulfoxide (DMSO) containing Triton B at room temperature produced the alcohol 3 in 88% overall yield. It is expected that there would be a trans-opening of the epoxide ring for 2, so the resulting epimers would differ in the relative configuration of the thioacetal bridge and the alcoholic group depending on the orientation of compounds 1 and 2 in the transition state. It was theorized that the orientation of 1 and 2 that produced the alcohol 3 would be unfavorable in non-polar solvents. Thus, desired stereochemistry was assigned to the alcohol 3, and this compound was used in the further synthesis.

The alcohol 3 was then converted into the acetate 4 via acetic anhydride-pyridine at room temperature with an overall yield of 90%. The acetate was then converted to the hydroxymethyl derivative 5 in three steps (1. TFA/room temperature; 2. ClCO₂Et/Et₃N-CH₂Cl₂/room temperature; 3. NaBH₄/CH₃OH-CH₂Cl₂/0 °C. Mesylation of 5 (MsCl/CH₃OH-Et₃N-CH₂Cl₂/0 °C), followed by lithium chloride treatment in DMF and hydrolysis (NaOCH₃/CH₃OH-CH₂Cl₂/room temperature) give the chloride 6 at a 95% overall yield. Adding phenyllithium slowly to a mixture of 6 and chloromethyl benzyl ether in excess in THF at 78 °C gave the benzylgliotoxin adduct 7 at 45% yield. Next, boron trichloride treatment of 7 in in methylene chloride at 0 °C yielded the gliotoxin anisaldehyde adduct 8 at 50% yield. Finally, acid oxidation of 8 followed by perchloric acid treatment in methylene chloride at room temperature yielded d,l-gliotoxin in a 65% yield. Spectroscopic analysis (NMR, ir, uv, MS) and TLC comparison showed that the synthetic substance was identical to natural gliotoxin.

Exposure and health effects

Environmental exposure

Exposure to fungal species that secrete gliotoxin is common because airborne Aspergillus fungal spores are ubiquitous in many environments. Regular environmental exposure does not typically cause illness, but can cause serious infections in immunosuppressed individuals or those with chronic respiratory illnesses. Infection caused by Aspergillus fungus is called aspergillosis. There are many types of aspergillosis, but infections typically affect the lungs or the sinuses.^[20]

Gliotoxin is hypothesized to be an important virulence factor in Aspergillus fumigatus.^[17] Experiments have demonstrated that gliotoxin is isolated in the highest concentrations from Aspergillus fumigatus in comparison to other Aspergillus species. This species of fungi is the most common cause of aspergillosis in humans. Gliotoxin is also the only toxin that has been isolated from the sera of patients with invasive aspergillosis. These results suggest a link between gliotoxin secretion and fungal pathogenicity.^[21]

While not enough data exists to definitively tie chronic gliotoxin exposure to the development of cancer, chronic exposure to other immunosuppressive agents has been linked to the development of lymphomas and mammary tumors. Individuals taking immunosuppressive medications or with previous or current exposure to chemotherapy radiation are at higher risk for the development of these tumors.^[22]

Clinical exposure

Gliotoxin is toxic if swallowed or inhaled, and can cause skin and eye irritation if exposure occurs to these areas. The oral LD₅₀ of gliotoxin is 67 mg/kg. Acute symptoms of gliotoxin start rapidly after ingestion.^[22]

Strategies for toxicity prevention

Understanding the mechanisms behind the toxicity of gliotoxin can open new possibilities for the use of gliotoxin therapeutically or as a diagnostic test for some conditions.^[18] One potential strategy that has been explored to reduce the toxicity of the fungi that produce gliotoxin is to target the gli gene cluster that controls the expression of gliotoxin protein.^[18] The disulfide bridge of gliotoxin is crucial to its toxicity, so it is theorized that the tailoring of enzymes to prevent the disulfide bridge closure by interfering with GliT or by catalyzing another reaction to block the sulfur residues may be beneficial in reducing the toxicity of those fungi.^[18] Another potential strategy is the targeting of the transcriptional activator GliZ, as deletion of the GliZ resulted in abrogated gliotoxin biosynthesis.^[17] This leads to the possible targeting of GliZ itself rather than any gene-based methodology to prevent it from binding to the gli gene cluster and activate transcription of the genes required for gliotoxin biosynthesis.^[18] One possible strategy for disrupting the regulation of gliotoxin transport is depleting the amount of GipA in the cell.^[18] GipA is a transcriptional regulator for the expression of the GliA transporter protein, which is required for gliotoxin secretion.^[18] These biosynthetic strategies for reducing the toxicity of pathogenic fungal strains that produce gliotoxin are still in their early stages of exploration but could provide novel methodologies for the adoption of therapeutic uses for gliotoxin.^[18]

Possible uses

While gliotoxin exposure at high concentrations shows cytotoxic effects via a multitude of different pathways, low-dose gliotoxin has been shown to have beneficial biological functions.^[18] Low-dose gliotoxin can exert antioxidant activities in the presence of the thioredoxin redox system that can counter the release of ROS in cells as a result of the electron transport chain (ETC) during cellular respiration.^[17]^[18] Moderate doses of gliotoxin have also been found to exhibit an anti-inflammatory effect in vivo due to the suppression of NF-κB activity by gliotoxin.^[18] Doses of gliotoxin less than 40 nM can also activate latent HIV-1 gene expression, serving as a diagnostic of HIV infection.^[18] Gliotoxin can activate HIV-1 expression by targeting (LARP7), which results in the release of active P-TEFb and the positive regulation of transcription of HIV proteins. Treatment of 20 nM gliotoxin reversed HIV-1 latency without interfering in the activation of CD4⁺ or CD8+ T-cells that are involved in the elimination of HIV-infected cells.^[18] While research on this possible gliotoxin use is in early stages, this provides a possible future direction for HIV diagnosis and treatment.^[18]

Related Research Articles

<span class="mw-page-title-main">Glutathione</span> Ubiquitous antioxidant compound in living organisms

Glutathione is an organic compound with the chemical formula HOCOCH(NH₂)CH₂CH₂CONHCH(CH₂SH)CONHCH₂COOH. It is an antioxidant in plants, animals, fungi, and some bacteria and archaea. Glutathione is capable of preventing damage to important cellular components caused by sources such as reactive oxygen species, free radicals, peroxides, lipid peroxides, and heavy metals. It is a tripeptide with a gamma peptide linkage between the carboxyl group of the glutamate side chain and cysteine. The carboxyl group of the cysteine residue is attached by normal peptide linkage to glycine.

Aflatoxins are various poisonous carcinogens and mutagens that are produced by certain molds, particularly Aspergillus species mainly by Aspergillus flavus and Aspergillus parasiticus. According to the USDA, "They are probably the best known and most intensively researched mycotoxins in the world." The fungi grow in soil, decaying vegetation and various staple foodstuffs and commodities such as hay, maize, peanuts, coffee, wheat, millet, sorghum, cassava, rice, chili peppers, cottonseed, tree nuts, sesame seeds, sunflower seeds, and various cereal grains and oil seeds. In short, the relevant fungi grow on almost any crop or food. When such contaminated food is processed or consumed, the aflatoxins enter the general food supply. They have been found in both pet and human foods, as well as in feedstocks for agricultural animals. Animals fed contaminated food can pass aflatoxin transformation products into milk, milk products, and meat. For example, contaminated poultry feed is the suspected source of aflatoxin-contaminated chicken meat and eggs in Pakistan.

Aspergillus niger is a mold classified within the Nigri section of the Aspergillus genus. The Aspergillus genus consists of common molds found throughout the environment within soil and water, on vegetation, in fecal matter, on decomposing matter, and suspended in the air. Species within this genus often grow quickly and can sporulate within a few days of germination. A combination of characteristics unique to A. niger makes the microbe invaluable to the production of many acids, proteins and bioactive compounds. Characteristics including extensive metabolic diversity, high production yield, secretion capability, and the ability to conduct post-translational modifications are responsible for A. niger's robust production of secondary metabolites. A. niger's capability to withstand extremely acidic conditions makes it especially important to the industrial production of citric acid.

Protein disulfide isomerase, or PDI, is an enzyme in the endoplasmic reticulum (ER) in eukaryotes and the periplasm of bacteria that catalyzes the formation and breakage of disulfide bonds between cysteine residues within proteins as they fold. This allows proteins to quickly find the correct arrangement of disulfide bonds in their fully folded state, and therefore the enzyme acts to catalyze protein folding.

<i>Aspergillus fumigatus</i> Species of fungus

Aspergillus fumigatus is a species of fungus in the genus Aspergillus, and is one of the most common Aspergillus species to cause disease in individuals with an immunodeficiency.

Aspergillus is a genus consisting of several hundred mold species found in various climates worldwide.

Citrinin is a mycotoxin which is often found in food. It is a secondary metabolite produced by fungi that contaminates long-stored food and it can cause a variety of toxic effects, including kidney, liver and cell damage. Citrinin is mainly found in stored grains, but sometimes also in fruits and other plant products.

Sulfur assimilation is the process by which living organisms incorporate sulfur into their biological molecules. In plants, sulfate is absorbed by the roots and then be transported to the chloroplasts by the transipration stream where the sulfur are reduced to sulfide with the help of a series of enzymatic reactions. Furthermore, the reduced sulfur is incorporated into cysteine, an amino acid that is a precursor to many other sulfur-containing compounds. In animals, sulfur assimilation occurs primarily through the diet, as animals cannot produce sulfur-containing compounds directly. Sulfur is incorporated into amino acids such as cysteine and methionine, which are used to build proteins and other important molecules.

Aspergillus terreus, also known as Aspergillus terrestris, is a fungus (mold) found worldwide in soil. Although thought to be strictly asexual until recently, A. terreus is now known to be capable of sexual reproduction. This saprotrophic fungus is prevalent in warmer climates such as tropical and subtropical regions. Aside from being located in soil, A. terreus has also been found in habitats such as decomposing vegetation and dust. A. terreus is commonly used in industry to produce important organic acids, such as itaconic acid and cis-aconitic acid, as well as enzymes, like xylanase. It was also the initial source for the drug mevinolin (lovastatin), a drug for lowering serum cholesterol.

Adenylyl-sulfate reductase (thioredoxin) is an enzyme that catalyzes the chemical reaction

Pathogenic fungi are fungi that cause disease in humans or other organisms. Although fungi are eukaryotic, many pathogenic fungi are microorganisms. Approximately 300 fungi are known to be pathogenic to humans; their study is called "medical mycology". Fungal infections are estimated to kill more people than either tuberculosis or malaria—about two million people per year.

<span class="mw-page-title-main">Ergocryptine</span> Chemical compound

Ergocryptine is an ergopeptine and one of the ergoline alkaloids. It is isolated from ergot or fermentation broth and it serves as starting material for the production of bromocriptine. Two isomers of ergocryptine exist, α-ergocryptine and β-ergocryptine. The beta differs from the alpha form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid leucine is replaced by isoleucine. β-Ergocryptine was first identified in 1967 by Albert Hofmann. Ergot from different sources have different ratios of the two isomers.

Aflatoxin B₁ is an aflatoxin produced by Aspergillus flavus and A. parasiticus. It is a very potent carcinogen with a TD₅₀ 3.2 μg/kg/day in rats. This carcinogenic potency varies across species with some, such as rats and monkeys, seemingly much more susceptible than others. Aflatoxin B₁ is a common contaminant in a variety of foods including peanuts, cottonseed meal, corn, and other grains; as well as animal feeds. Aflatoxin B₁ is considered the most toxic aflatoxin and it is highly implicated in hepatocellular carcinoma (HCC) in humans. In animals, aflatoxin B₁ has also been shown to be mutagenic, teratogenic, and to cause immunosuppression. Several sampling and analytical methods including thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), mass spectrometry, and enzyme-linked immunosorbent assay (ELISA), among others, have been used to test for aflatoxin B₁ contamination in foods. According to the Food and Agriculture Organization (FAO), a division of the United Nations, the worldwide maximum tolerated levels of aflatoxin B₁ was reported to be in the range of 1–20 μg/kg (or .001 ppm - 1 part-per-billion) in food, and 5–50 μg/kg (.005 ppm) in dietary cattle feed in 2003.

Bacterial glutathione transferases are part of a superfamily of enzymes that play a crucial role in cellular detoxification. The primary role of GSTs is to catalyze the conjugation of glutathione (GSH) with the electrophilic centers of a wide variety of molecules. The most commonly known substrates of GSTs are xenobiotic synthetic chemicals. There are also classes of GSTs that utilize glutathione as a cofactor rather than a substrate. Often these GSTs are involved in reduction of reactive oxidative species toxic to the bacterium. Conjugation with glutathione receptors renders toxic substances more soluble, and therefore more readily exocytosed from the cell.

Chronic pulmonary aspergillosis is a long-term fungal infection caused by members of the genus Aspergillus—most commonly Aspergillusfumigatus. The term describes several disease presentations with considerable overlap, ranging from an aspergilloma—a clump of Aspergillus mold in the lungs—through to a subacute, invasive form known as chronic necrotizing pulmonary aspergillosis which affects people whose immune system is weakened. Many people affected by chronic pulmonary aspergillosis have an underlying lung disease, most commonly tuberculosis, allergic bronchopulmonary aspergillosis, asthma, or lung cancer.

Chanoclavine-I dehydrogenase (EC 1.1.1.332, easD (gene), fgaDH (gene)) is an enzyme with systematic name chanoclavine-I:NAD⁺ oxidoreductase. This enzyme catalises the following chemical reaction

Pseurotin A is a secondary metabolite of Aspergillus.

<span class="mw-page-title-main">L-ornithine N5 monooxygenase</span> Enzyme

L-ornithine N5 monooxygenase (EC 1.14.13.195 or EC 1.14.13.196) is an enzyme which catalyzes one of the following chemical reactions:

L-ornithine + NADPH + O₂ $N(5)-hydroxy-L-ornithine + NADP + + H 2 O L-ornithine + NAD(P)H + O 2 N(5)-hydroxy-L-ornithine + NAD(P) + + H 2 O$

Aspergillus viridinutans is a species of fungus in the genus Aspergillus. The species was first isolated in Frankston, Victoria, Australia and described in 1954. It is from the Fumigati section of Aspergillus. Several fungi from this section produce heat-resistant ascospores, and the isolates from this section are frequently obtained from locations where natural fires have previously occurred. A. viridinutans has been identified as the cause of chronic aspergillosis. The mycotoxin viriditoxin was first identified in A. viridinutans. A draft genome sequence of the strain derived from the original species description has been generated.

<span class="mw-page-title-main">Viriditoxin</span> Chemical compound

Viriditoxin (VDT) is a secondary metabolite produced by fungi. Viriditoxin is a type of mycotoxin. The biosynthesis of the compound has been investigated.

References

↑ Borthwick AD (2012). "2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products". Chemical Reviews. 112 (7): 3641–3716. doi:10.1021/cr200398y. PMID 22575049.
↑ Jiang CS, Muller WE, Schroder HC, Guo YW (2012). "Disulfide- and Multisulfide-Containing Metabolites from Marine Organisms". Chem. Rev. 112 (4): 2179–2207. doi:10.1021/cr200173z. PMID 22176580.
↑ Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA (January 2005). "Detection of Gliotoxin in Experimental and Human Aspergillosis". Infection and Immunity. 73 (1): 635–637. doi:10.1128/IAI.73.1.635-637.2005. PMC 538950 . PMID 15618207.
↑ Scharf DH, Heinekamp T, Remme N, Hortschansky P, Brakhage AA, Hertweck C (2012). "Biosynthesis and function of gliotoxin in Aspergillus fumigatus". Appl Microbiol Biotechnol. 93 (2): 467–72. doi:10.1007/s00253-011-3689-1. PMID 22094977. S2CID 689907.
↑ Shah DT, Larsen B (1991). "Clinical isolates of yeast produce a gliotoxin-like substance". Mycopathologia. 116 (3): 203–8. doi:10.1007/BF00436836. PMID 1724551. S2CID 12919491.
↑ Kupfahl C, Ruppert T, Dietz A, Geginat G, Hof H (2007). "Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro". FEMS Yeast Res. 7 (6): 986–92. doi: 10.1111/j.1567-1364.2007.00256.x . PMID 17537180.
↑ Kosalec I, Puel O, Delaforge M, Kopjar N, Antolovic R, Jelic D, Matica B, Galtier P, Pepeljnjak S (2010). "Isolation and cytotoxicity of low-molecular-weight metabolites of Candida albicans". Front Biosci. 13 (13): 6893–904. doi: 10.2741/3197 . PMID 18508703.
↑ Knowles SL, Mead ME, Silva LP, Raja HA, Steenwyk JL, Goldman GH, Oberlies NH, Rokas A (25 February 2020). "Gliotoxin, a Known Virulence Factor in the Major Human Pathogen Aspergillus fumigatus, Is Also Biosynthesized by Its Nonpathogenic Relative Aspergillus fischeri". mBio. 11 (1): e03361–19. doi:10.1128/mBio.03361-19. PMC 7018655 . PMID 32047138. S2CID 211084907.
↑ Kwon-Chung KJ, Sugui JA (January 2009). "What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus?". Medical Mycology. 47 (s1): S97–S103. doi:10.1080/13693780802056012. PMC 2729542 . PMID 18608908. S2CID 9504461.
↑ Johnson JR, Bruce WF, Dutcher JD (October 1943). "Gliotoxin, The Antibiotic Principle of Gliocladium fimbriatum. I. Production, Physical and Biological Properties 1". Journal of the American Chemical Society. 65 (10): 2005–2009. doi:10.1021/ja01250a051. ISSN 0002-7863.
1 2 Carberry S, Molloy E, Hammel S, O'Keeffe G, Jones GW, Kavanagh K, Doyle S (1 April 2012). "Gliotoxin effects on fungal growth: Mechanisms and exploitation" (PDF). Fungal Genetics and Biology. 49 (4): 302–312. doi:10.1016/j.fgb.2012.02.003. ISSN 1087-1845. PMID 22405895. Archived (PDF) from the original on 20 December 2016. Retrieved 5 January 2024.
1 2 Brian PW (November 1944). "Production of Gliotoxin by Trichoderma viride". Nature. 154 (3917): 667–668. Bibcode:1944Natur.154R.667B. doi:10.1038/154667b0. ISSN 1476-4687. S2CID 4133538. Archived from the original on 2023-05-07. Retrieved 2023-05-10.
1 2 Bell MR, Johnson JR, Wildi BS, Woodward RB (February 1958). "The Structure of Gliotoxin". Journal of the American Chemical Society. 80 (4): 1001. doi:10.1021/ja01537a065. ISSN 0002-7863.
1 2 3 4 McDougall JK (1969). "Antiviral action of gliotoxin". Archiv für die gesamte Virusforschung. 27 (2–4): 255–267. doi:10.1007/BF01249648. PMID 4313024. S2CID 7184381.
↑ Kwon-Chung KJ, Sugui JA (2009). "What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus?". Medical Mycology. 47 (Suppl 1): S97–103. doi:10.1080/13693780802056012. PMC 2729542 . PMID 18608908.
1 2 Pardo J, Urban C, Galvez EM, Ekert PG, Müller U, Kwon-Chung J, Lobigs M, Müllbacher A, Wallich R, Borner C, Simon MM (2006). "The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillusfumigatus virulence in mice". The Journal of Cell Biology. 174 (4): 509–19. doi:10.1083/jcb.200604044. PMC 2064257 . PMID 16893972.
1 2 3 4 5 6 7 8 Dolan SK, o'Keeffe G, Jones GW, Doyle S (2015). "Resistance is not futile: Gliotoxin biosynthesis, functionality and utility" (PDF). Trends in Microbiology. 23 (7): 419–28. doi:10.1016/j.tim.2015.02.005. PMID 25766143. Archived (PDF) from the original on 2018-07-19. Retrieved 2019-07-14.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Ye W, Liu T, Zhang W, Zhang W (16 December 2021). "The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention". International Journal of Molecular Sciences. 22 (24): 13510. doi: 10.3390/ijms222413510 . PMC 8705807 . PMID 34948306.
1 2 Fukuyama T, Kishi Y (October 1976). "A total synthesis of gliotoxin". Journal of the American Chemical Society. 98 (21): 6723–6724. doi:10.1021/ja00437a063. ISSN 0002-7863. PMID 61223.
↑ The Aspergillosis Website . (n.d.). Aspergillus & Aspergillosis Website. Retrieved May 08, 2017, from http://www.aspergillus.org.uk/content/aspergillosis-2 Archived 2020-08-06 at the Wayback Machine
↑ Dagenais TR, Keller NP (2009). "Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis". Clinical Microbiology Reviews. 22 (3): 447–65. doi:10.1128/cmr.00055-08. PMC 2708386 . PMID 19597008.
1 2 "Safety Data Sheet: Gliotoxin" (PDF). Archived (PDF) from the original on 2021-03-25. Retrieved 2017-05-08.